Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases-Reply.
Saved in:
| Title: | Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases-Reply. |
|---|---|
| Authors: | Syversen SW; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway., Bolstad N; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway., Haavardsholm EA; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway. |
| Source: | JAMA [JAMA] 2021 Sep 21; Vol. 326 (11), pp. 1069-1070. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1538-3598 |
|---|---|
| DOI: | 10.1001/jama.2021.11480 |
